NCT06708949 · Interventional trial
A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)
Overall registry status Active not recruiting
Phase 2
Conditions Renal Cell Carcinoma, Clear Cell
Delaware Valley sites
- Penn Medicine Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory